目前设计针对N-myristoyltransferase的抗疟疾药物的趋势
Misael de Azevedo Teotônio Cavalcanti1,2, Karla Joane Da Silva Menezes2,3, Jéssika De Oliveira Viana4
1Postgraduate Program of Pharmaceutical Sciences, Pharmacy Department, State University of Paraíba, Campina, Grande-PB, Brazil.
Future microbiology
|October 23, 2024
概括
针对N-myristoyltransferase (NMT) 的新型抗疟疾药物由于增加药物耐药性而至关重要. 本综述探讨了设计新型抗寄生虫化合物的最新进展,这些化合物可以抑制Plasmodium NMT.
科学领域:
- *分子寄生虫学和药物发现.
- * 蛋白质修饰的生物化学和酶学.
背景情况:
- * 疟疾是由虫寄生虫引起的,是全球卫生面临的重大挑战.
- * 现有的抗疟疾治疗因原生动物的广泛耐药性而受到损害.
- *N-myristoyltransferase (NMT) 是Plasmodium中的一种必不可少的酶,对蛋白质功能至关重要.
研究的目的:
- * 审查最近开发针对Plasmodium NMT的抗疟疾药物的进展.
- *强调NMT作为治疗疟疾的新型药物标的重要性.
主要方法:
- * 关于抗疟疾药物开发的科学出版物的文献综述.
- *研究分析,重点关注N-myristoyltransferase在Plasmodium中的结构和功能.
- * 对旨在抑制Plasmodium NMT的新型化学实体的检查.
主要成果:
- *NMT在虫寄生虫的生存和毒性中起着至关重要的作用.
- * 几个类型的NMT抑制剂在临床前研究中显示出有前途的抗疟疾活性.
- * 向Plasmodium NMT提供了一种潜在的策略来克服现有的耐药性.
结论:
- *N-myristoyltransferase代表了一种有希望和验证的目标,用于新型抗疟疾药物的发现.
- *对NMT抑制剂的持续研究对于开发有效的抗药性疟疾治疗方法至关重要.
- * 开发特定于Plasmodium NMT的药物可能为疟疾控制提供新的治疗途径.
相关概念视频
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
01:28Structure-Activity Relationships and Drug Design
622
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
622